EWM
ADMA icon

Empirical Wealth Management’s ADMA Biologics ADMA Stock Holding History

Empirical Wealth Management’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$320K Buy
38,242
+18,178
+91% +$166K ﹤0.01% 848
2026
Q1 		$181K Buy
20,064
+5,338
+36% +$84.2K ﹤0.01% 955
2025
Q4 		$269K Buy
+14,726
New +$248K ﹤0.01% 732

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Empirical Wealth Management's ADMA Position: Q2 2026 in Review

Empirical Wealth Management increased its ADMA Biologics (ADMA) stake by 91% in Q2 2026, buying an estimated $166K and bringing the position to 38,242 shares worth $320K. The position accounts for ﹤0.01% of the portfolio, ranked #848.

Empirical Wealth Management first reported a position in ADMA in Q4 2025 and has held it in 3 quarters since. 163 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Empirical Wealth Management held 38,242 shares of ADMA Biologics worth $320K as of Q2 2026.
  • Empirical Wealth Management bought 18,178 ADMA Biologics shares in Q2 2026, an estimated $166K.
  • ADMA Biologics made up ﹤0.01% of Empirical Wealth Management's portfolio in Q2 2026, its #848 holding.
  • Empirical Wealth Management first reported a position in ADMA Biologics in Q4 2025 and has held it in 3 quarters since.
  • 163 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Empirical Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.